NASDAQ:MRKR
Marker Therapeutics Inc. Stock News
$4.13
-0.100 (-2.36%)
At Close: May 10, 2024
300,000 sign petition calling for 'opt-out' on sending children back to school
07:02am, Monday, 11'th May 2020
It comes as schools are making plans to reopen within weeks
Reopening schools too early will cause a surge in death rates, scientists have warned
01:45pm, Sunday, 10'th May 2020Education unions set out key tests for reopening schools
11:41am, Saturday, 09'th May 2020
The London Economic |The measures include extra money for deep cleaning and personal protective equipment, before they will agree to open schools| News
Key tests for reopening schools have been laid out by education chiefs
09:54am, Saturday, 09'th May 2020
Measures include extra money for deep cleaning and personal protective equipment
Teachers warn against schools re-opening until ‘test, trace and isolate’ system is rolled out
04:02pm, Friday, 08'th May 2020
Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological mal
Revealed: year six primary school pupils may return on 1 June
05:22pm, Sunday, 03'rd May 2020
Boris Johnson set to announce 10- and 11-year-olds will be first to attend when schools reopen
Primary schools in England could reopen on 1 June, reports suggest
12:18pm, Sunday, 03'rd May 2020
Boris Johnson says he wants primary schools back ‘as fast as we can’ as coronavirus pandemic continues
Moderna Covid Drug Production Deal, And Other News: The Good, Bad And Ugly Of Biopharma
09:02am, Sunday, 03'rd May 2020
Moderna makes deal with Lonza to boost mRNA 1273 production. Marker receives orphan drug designation for AML drug. Jazz halts defibrotide trial on lack of posit
Mid-Afternoon Market Update: Dow Slides 350 Points; Kraton Shares Rise On Upbeat Results
06:41pm, Thursday, 30'th Apr 2020
Toward the end of trading Thursday, the Dow traded down 1.42% to 24283.25 while the NASDAQ fell 0.81% to 8842.12. The S&P also fell, dropping 1.31% to 2,900.91.
The U.S. is...
Mid-Day Market Update: Crude Oil Surges 20%; Chesapeake Energy Shares Plunge
04:28pm, Thursday, 30'th Apr 2020
Midway through trading opening Thursday, the Dow traded down 1.02% to 24,384.04 while the NASDAQ fell 0.14% to 8,901.91. The S&P also fell, dropping 0.74% to 2,917.83.
The U.S...
OSTK, AR among premarket gainers
01:20pm, Thursday, 30'th Apr 2020
LMP Automotive Holdings (NASDAQ:LMPX) +35%.AgEagle Aerial Systems (NYSEMKT:UAVS) +27%.Soligenix (NASDAQ:SNGX) +25% on positive SGX301 data.Secoo Holding (NASDAQ:SECO) +26% on share repurchase progra
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
13 Stocks Moving In Wednesday's After-Hours Session
09:45pm, Wednesday, 29'th Apr 2020
Gainers
Microsoft (NASDAQ: MSFT) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.
Qualcomm (NASDAQ: QCOM) shares are trading...
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia
08:05pm, Wednesday, 29'th Apr 2020
Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological mal
